OncoType Dx: Prediciendo la Recurrencia del Cáncer

This article has been moved to a new location
View article


My Cancer Experience
by Bob Riter
October 06, 2015

Related News

FDA Approves Keytruda for Advanced NSCLC

Oct 5, 2015

Approved for use with PD-L1 IHC 22C3 pharmDx test

High False-Negative Rate for HER2 Status Using Oncotype DX

Oct 13, 2011

HER2 status in breast cancer with RT-PCR assay is discordant with IHC/FISH results


Aug 31, 2010